GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » Equity-to-Asset

BSPK (Bespoke Extracts) Equity-to-Asset : -6.89 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bespoke Extracts's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-2.33 Mil. Bespoke Extracts's Total Assets for the quarter that ended in Sep. 2024 was $0.34 Mil. Therefore, Bespoke Extracts's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was -6.89.

The historical rank and industry rank for Bespoke Extracts's Equity-to-Asset or its related term are showing as below:

BSPK' s Equity-to-Asset Range Over the Past 10 Years
Min: -57   Med: -1.69   Max: 0.99
Current: -6.89

During the past 13 years, the highest Equity to Asset Ratio of Bespoke Extracts was 0.99. The lowest was -57.00. And the median was -1.69.

BSPK's Equity-to-Asset is ranked worse than
97.77% of 1033 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs BSPK: -6.89

Bespoke Extracts Equity-to-Asset Historical Data

The historical data trend for Bespoke Extracts's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts Equity-to-Asset Chart

Bespoke Extracts Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -3.10 -3.34 -1.64 -4.87

Bespoke Extracts Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.01 -4.87 -5.54 -5.92 -6.89

Competitive Comparison of Bespoke Extracts's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bespoke Extracts's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's Equity-to-Asset falls into.


;
;

Bespoke Extracts Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bespoke Extracts's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-1.725/0.354
=-4.87

Bespoke Extracts's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=-2.329/0.338
=-6.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bespoke Extracts  (OTCPK:BSPK) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bespoke Extracts Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bespoke Extracts's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bespoke Extracts Business Description

Traded in Other Exchanges
N/A
Address
12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.
Executives
Michael Feinsod director, 10 percent owner, officer: CEO
Tyler Hunter Garth director, officer: President 6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack 10 percent owner, officer: President and CEO 6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel 10 percent owner, officer: President and CEO 1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr director, 10 percent owner, officer: President and CEO 1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich 10 percent owner 971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd. 10 percent owner 402 W. DAVIS, LULING TX 78648
Barry Tenzer director, 10 percent owner, officer: President, CEO, CFO 290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata director, 10 percent owner, officer: Executive VP 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser 10 percent owner 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027